Company profile
Vectura Group plc is a pulmonary drug development company focused principally on the development of a range of inhaled pharmaceuticals for the treatment of respiratory and neurological diseases.
Vectura has eight marketed products and a portfolio of drugs in clinical and pre-clinical development, some of which have been licensed to major pharmaceutical companies. The Company also progresses certain programmes to a more advanced stage to optimise their commercial value. In addition, Vectura offers its formulation and inhalation capabilities to other pharmaceutical companies on a licensing basis where this complements Vectura’s business strategy.
Vectura is based in the UK, with headquarters and development operations in Chippenham, Wiltshire, further laboratories in Nottingham, and device development in Cambridge.
Vectura's shares trade on the London Stock Exchange under the symbol VEC.
